259 related articles for article (PubMed ID: 7870215)
1. The value of bone marrow biopsy in the prognosis of hairy cell leukemia (HCL).
Podzimek K; Kerekes Z; Chrobák L; Skalská H; Voglová J; Mirová S; Dulícek P; Zák P
Neoplasma; 1994; 41(6):325-30. PubMed ID: 7870215
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow in hairy cell leukemia.
Katayama I
Hematol Oncol Clin North Am; 1988 Dec; 2(4):585-602. PubMed ID: 3065320
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
Urasiński I; Zdziarska B; Krygier-Stojałowska A
Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
6. The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission.
Zák P; Chrobák L; Dedic K
Neoplasma; 2001; 48(1):72-5. PubMed ID: 11327542
[TBL] [Abstract][Full Text] [Related]
7. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
[TBL] [Abstract][Full Text] [Related]
9. [3 clinico-hematologic variants of hairy-cell leukemia].
Iavorkovskiĭ LL; Soloveĭ DIa; Riauzova LIu; Zilev MA; Sused SG
Ter Arkh; 1989; 61(7):23-6. PubMed ID: 2588137
[TBL] [Abstract][Full Text] [Related]
10. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic relevancy of histomorphological bone marrow findings in chronic lymphocytic leukemia (CLL)].
Wutke K; Scheibner K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):218-30. PubMed ID: 6194055
[TBL] [Abstract][Full Text] [Related]
12. Histomorphology of multiple myeloma on bone marrow biopsy.
Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
[TBL] [Abstract][Full Text] [Related]
13. T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines.
Jöhrens K; Stein H; Anagnostopoulos I
Am J Surg Pathol; 2007 Aug; 31(8):1181-5. PubMed ID: 17667540
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
15. Hairy cell leukemia and other "hairy-cell" lymphoproliferative disorders (LPD-HC): the significance of morphologic, histologic and immunologic studies.
Yavorkovsky LL; Gipsh NM; Karminskaya NM; Udris OYu ; Nikulshin SV; Yavorkovsky LI
Neoplasma; 1990; 37(4):439-44. PubMed ID: 2234204
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
Zák P; Chrobák L; Dĕdic K; Podzimek K
Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
[TBL] [Abstract][Full Text] [Related]
17. Marrow mast cell hyperplasia in hairy cell leukemia.
Macon WR; Kinney MC; Glick AD; Collins RD
Mod Pathol; 1993 Nov; 6(6):695-8. PubMed ID: 8302811
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the mechanisms of hairy-cell localization in tissues and the process of the bone marrow fibrosis in hairy-cell leukemia.
Aziz KA
Saudi Med J; 2003 Jul; 24(7):715-9. PubMed ID: 12883600
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
Molica S; Tucci L; Levato D; Docimo C
Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
